AGPU - Predictive Oncology Inc.

4.88
0.260   5.328%

Share volume: 208,009
Last Updated: 04-21-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$4.62
0.26
0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
25%
Profitability 25%
Dept financing 23%
Liquidity 11%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
38.64%
1 Month
199.39%
3 Months
-18.53%
6 Months
-47.19%
1 Year
446.90%
2 Year
313.56%
Key data
Stock price
$4.88
P/E Ratio 
0.00
DAY RANGE
$4.21 - $5.00
EPS 
-$108.50
52 WEEK RANGE
$0.71 - $16.54
52 WEEK CHANGE
$409.77
MARKET CAP 
10.326 M
YIELD 
N/A
SHARES OUTSTANDING 
3.394 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
1.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$230,128
AVERAGE 30 VOLUME 
$5,002,116
Company detail
CEO: Raymond F. Vennare
Region: US
Website: predictive-oncology.com
Employees: 30
IPO year: 2010
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Predictive Oncology Inc. focuses on developing personalized cancer therapies using artificial intelligence (AI) The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures.

Recent news